These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38974777)

  • 1. Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study.
    Park JN; Serafinski R; Ujeneza M; McKenzie M; Tardif J; Krotulski AJ; Badea A; Grossman ER; Green TC
    Drug Alcohol Depend Rep; 2024 Jun; 11():100247. PubMed ID: 38974777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive testing and rapid dissemination of local drug supply surveillance data in Rhode Island.
    Collins AB; Wightman RS; Macon EC; Guan Y; Shihipar A; Krieger M; Elmaleh R; Smith MC; Morales A; Badea A
    Int J Drug Policy; 2023 Aug; 118():104118. PubMed ID: 37422985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods.
    Thompson E; Tardif J; Ujeneza M; Badea A; Green TC; McKee H; McKenzie M; Park JN
    Drug Alcohol Depend Rep; 2024 Jun; 11():100241. PubMed ID: 38808200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costing analysis of a point-of-care drug checking program in Rhode Island.
    Cepeda JA; Thompson E; Ujeneza M; Tardif J; Walsh T; Morales A; Rosen JG; Green TC; Park JN
    Drug Alcohol Depend; 2023 Dec; 253():111028. PubMed ID: 38000322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study.
    Aronson ID; Ardouin-Guerrier MA; Baus JE; Bennett AS
    JMIR Form Res; 2024 Jul; 8():e56755. PubMed ID: 38959505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications.
    Bowles JM; McDonald K; Maghsoudi N; Thompson H; Stefan C; Beriault DR; Delaney S; Wong E; Werb D
    Harm Reduct J; 2021 Oct; 18(1):104. PubMed ID: 34645480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and Uptake of the Massachusetts Drug Supply Data Stream: A Statewide Public Health-Public Safety Partnership Drug Checking Program.
    Green TC; Olson R; Jarczyk C; Erowid E; Erowid F; Thyssen S; Wightman R; Del Pozo B; Michelson L; Consigli A; Reilly B; Ruiz S
    J Public Health Manag Pract; 2022 Nov-Dec 01; 28(Suppl 6):S347-S354. PubMed ID: 36194805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
    Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
    Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
    Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
    Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
    Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services.
    Wagner KD; Fiuty P; Page K; Tracy EC; Nocera M; Miller CW; Tarhuni LJ; Dasgupta N
    Drug Alcohol Depend; 2023 Nov; 252():110985. PubMed ID: 37826988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of North American drug checking services operating in 2022.
    Park JN; Tardif J; Thompson E; Rosen JG; Lira JAS; Green TC
    Int J Drug Policy; 2023 Nov; 121():104206. PubMed ID: 37797571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses - Eight Syringe Services Programs, Maryland, November 2021-August 2022.
    Russell E; Sisco E; Thomson A; Lopes J; Rybak M; Burnett M; Heilman D; Appley MG; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(17):458-462. PubMed ID: 37104171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine.
    Jawa R; Blakemore S; Murray S; Ventura AS; Hristova T; Wilder A; Shang M; Johnson T; LaBelle C
    J Addict Med; 2024 Jul; ():. PubMed ID: 39051898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips.
    Reed MK; Imperato NS; Bowles JM; Salcedo VJ; Guth A; Rising KL
    Drug Alcohol Depend Rep; 2022 Sep; 4():100074. PubMed ID: 36846574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods.
    Laing MK; Ti L; Marmel A; Tobias S; Shapiro AM; Laing R; Lysyshyn M; Socías ME
    Int J Drug Policy; 2021 Jul; 93():103169. PubMed ID: 33627302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
    Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
    Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding sensitivity and cross-reactivity of xylazine lateral flow immunoassay test strips for drug checking applications.
    Sisco E; Nestadt DF; Bloom MB; Schneider KE; Elkasabany RA; Rouhani S; Sherman SG
    Drug Test Anal; 2023 Dec; ():. PubMed ID: 38043944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA.
    Warp PV; Hauschild M; Serota DP; Ciraldo K; Cruz I; Bartholomew TS; Tookes HE
    Harm Reduct J; 2024 Mar; 21(1):64. PubMed ID: 38491467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
    Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
    Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.